The global big data analytics in healthcare market size was USD 47.37 billion in 2023, calculated at USD 56.47 billion in 2024 and is expected to be worth around USD 327.57 billion by 2034. The market is slated to expand at 19.22% CAGR from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Big Data Analytics in Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Big Data Analytics in Healthcare Market, by Spender, 2024-2034
8.1.1. Healthcare Provider
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Healthcare Payer
9.1. Big Data Analytics in Healthcare Market, by Tool, 2024-2034
9.1.1. Financial Analytics
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Data Warehouse Analytics
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. CRM Analytics
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Production Reporting
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Visual Analytics
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Predictive Analytics
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Supply Chain Analytics
9.1.7.1. Market Revenue and Forecast (2021-2034)
9.1.8. Risk Management Analytics
9.1.8.1. Market Revenue and Forecast (2021-2034)
9.1.9. Test Analytics
9.1.9.1. Market Revenue and Forecast (2021-2034)
9.1.10. Others
9.1.10.1. Market Revenue and Forecast (2021-2034)
10.1. Big Data Analytics in Healthcare Market, by Application, 2024-2034
10.1.1. Access Clinical Information
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Access Transactional Data
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Access Operational Information
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. Big Data Analytics in Healthcare Market, by Deployment, 2024-2034
11.1.1. On-premises
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Cloud-based
12.1. North America
12.1.1. Market Revenue and Forecast, by Spender (2021-2034)
12.1.2. Market Revenue and Forecast, by Tool (2021-2034)
12.1.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Spender (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Tool (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Spender (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Tool (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Spender (2021-2034)
12.2.2. Market Revenue and Forecast, by Tool (2021-2034)
12.2.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Spender (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Tool (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Spender (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Tool (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Spender (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Tool (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Spender (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Tool (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Spender (2021-2034)
12.3.2. Market Revenue and Forecast, by Tool (2021-2034)
12.3.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Spender (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Tool (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Spender (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Tool (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Spender (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Tool (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Spender (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Tool (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Spender (2021-2034)
12.4.2. Market Revenue and Forecast, by Tool (2021-2034)
12.4.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Spender (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Tool (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Spender (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Tool (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Spender (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Tool (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Spender (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Tool (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Spender (2021-2034)
12.5.2. Market Revenue and Forecast, by Tool (2021-2034)
12.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Spender (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Tool (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Spender (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Tool (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.4. Market Revenue and Forecast, by Deployment (2021-2034)
13.1. Allscripts Healthcare Solutions
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Alteryx
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Cisco Systems Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Denodo Technologies Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. IBM Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Infosys
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. McKesson
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. MedeAnalytics
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Microsoft Corp
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. OptumHealth Care Solutions
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample